1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodomains.
- DOI
- 10.1002/ardp.202200288
- Published
- 2022 Nov
- Container
- Archiv der Pharmazie
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ardp.202200288,
title = {1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodomains.},
author = {Jiang J and Zhao PL and Sigua LH and Chan A and Schönbrunn E and Qi J and Georg GI},
year = {2022},
journal = {Archiv der Pharmazie},
doi = {10.1002/ardp.202200288},
url = {https://doi.org/10.1002/ardp.202200288}
}RIS
TY - JOUR TI - 1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodomains. AU - Jiang J AU - Zhao PL AU - Sigua LH AU - Chan A AU - Schönbrunn E AU - Qi J AU - Georg GI PY - 2022 JO - Archiv der Pharmazie DO - 10.1002/ardp.202200288 UR - https://doi.org/10.1002/ardp.202200288 ER -
APA
J, J., PL, Z., LH, S., A, C., E, S., J, Q., & GI, G. (2022). 1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodomains.. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202200288
Source records
- pubmed · retrieved 2026-09-25T18:04:14.623Z